Tuberculosis News and Research

Latest Tuberculosis News and Research

Global Health Frontline News examines clean cookstove efforts in Tanzania

Global Health Frontline News (GHFN) reports on efforts to produce and provide clean cookstoves to people in Tanzania.

30 Jan 2012

Ban calls on business leaders to increase investment in women's education, health at WEF

Speaking at an event organized by the Every Woman Every Child initiative on Thursday, "Secretary-General Ban Ki-moon [called on] business leaders attending the World Economic Forum (WEF) in Davos, Switzerland, to increase their investment in women's education and health to ensure their well-being and encourage their participation in the world economy," the U.N. News Centre reports.

30 Jan 2012

Nanotechnology firm to develop test for handheld biosensors to detect deadly pathogens

A new company formed around Michigan State University nanotechnology promises to move speedy detection of deadly pathogens and toxins from the laboratory directly to the field.

30 Jan 2012

Two initiatives launched at WEF with aim of ending new HIV infections among children by 2015

"Two groundbreaking initiatives, aimed at realistically achieving the once-unthinkable goal of ending new HIV infections among children by the end of 2015, were launched simultaneously at the World Economic Forum's Annual Conference in Davos" on Friday, according to a Business Leadership Council press release.

30 Jan 2012

Addressing TB prevention, treatment among migrant populations

In this post on USAID's "IMPACTblog," Christina Lau, USAID health officer for Central Asia, discusses tackling tuberculosis in migrant populations, writing, "Most migrants are unable to access the health care system because they are undocumented laborers, who lack proper identification documents required for health care treatment, and who fear deportation if their documentation status becomes known."

30 Jan 2012

Watching transformation of the Global Fund on its 10th anniversary

"Are we watching the rebirth of the troubled Global Fund to Fight Aids, Tuberculosis and Malaria, perhaps in a new, more U.S.-flavored guise?" Guardian health editor Sarah Boseley asks in her "Global Health Blog."

27 Jan 2012

Responding to emergence of drug-resistant tuberculosis

This post in the Center for Strategic and International Studies' "Smart Global Health" blog examines drug-resistant tuberculosis (TB), stating, "[S]ince the recent outbreak of the so-called totally drug-resistant tuberculosis (TDR-TB) in India, TB has a new face."

27 Jan 2012

Reflecting on Global Fund's decade of accomplishment, looking forward to challenges ahead

"This week marks the 10th anniversary of the creation of the Global Fund to Fight AIDS, Tuberculosis and Malaria -- the world's most powerful tool for improving health -- at the World Economic Forum (WEF) in Davos, Switzerland," Natasha Bilimoria, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, writes in this post in the AlertNet "Insight" blog.

27 Jan 2012

Gates pledges $750 million to Global Fund

Speaking at the World Economic Forum in Davos, Switzerland, on Thursday, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, pledged $750 million on behalf of the foundation to the Geneva-based Global Fund to Fight AIDS, Tuberculosis and Malaria, the Associated Press reports.

27 Jan 2012

Gates urges governments, wealthy donors not to cut aid to poor countries; Annual letter sets foundation's priorities

In a speech to the European Parliament on Tuesday, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, "told European lawmakers in Brussels not to cut aid to poor countries despite the economic and budgetary problems facing" European Union (E.U.) countries, Agence France-Presse reports.

27 Jan 2012

First Edition: January 26, 2012

Today's health policy headlines include reports about House GOP plans to offer a 'replace' bill after the Supreme Court rules on the health law.

26 Jan 2012

Latest attacks in Jonglei, South Sudan, perpetuate a pattern of extreme violence, says Médecins Sans Frontières

In the state of Jonglei in South Sudan, civilians continue to bear the brunt of inter-communal fighting. Wounded patients are still arriving at the Médecins Sans Frontières hospital in Pibor, three weeks after the violent attack on the town and outlying villages in Pibor County. Many were injured in the bush, where thousands have remained, afraid to come out of hiding. Médecins Sans Frontières medical teams are now treating serious wound infections, some several weeks old. Since re-launching emergency medical activities in Pibor on 7 January, Médecins Sans Frontières has treated 47 patients with gunshot wounds – 16 women and 8 children. A further 43 patients have so far been treated for stab wounds, beatings or wounds sustained while fleeing in the bush.

24 Jan 2012

Address drug resistant pathogens as part of 'next stage of global health'

This post in the Foreign Policy Association blog discusses reports from earlier this month of "an emerging strain of 'totally drug-resistant' tuberculosis (TDR-TB)" in India, which the Indian government last week denied, "arguing that the 12 cases were in fact extensively drug resistant (XDR)."

24 Jan 2012

U.S. should assume leadership role in saving Global Fund

A funding shortfall led the Global Fund to Fight AIDS, Tuberculosis and Malaria to announce in November that "it won't make any grants to fund programs for at least two years," a Deseret News editorial notes and calls on the U.S. to take a leadership position in saving the fund.

24 Jan 2012

International HIV/AIDS Alliance releases report examining potential effects of Global Fund shortfall

The non-governmental organization (NGO) International HIV/AIDS Alliance has released a new report in response to the Global Fund to Fight AIDS, Tuberculosis and Malaria's announcement in November that "no new grants would be approved until 2014," VOA News reports.

24 Jan 2012

Cooperation needed to fight TB

In this post in Global Health Frontline News' "Notes From the Field" blog, Kevin Cain, chief of the tuberculosis (TB) branch for a research and public health collaboration between the Kenya Medical Research Institute (KEMRI) and the CDC in Kisumu, Kenya, reports on TB research underway as part of the collaboration.

23 Jan 2012

India's Ministry of Health dismisses claims of 'totally drug-resistant' TB

In a January 17 statement, India's Ministry of Health and Family Welfare "dismissed reports that a form of incurable tuberculosis [TB] has arrived in the country," saying "that a team of doctors sent by the ministry found that seven of the patients are responding to treatment" and the cases would be classified and managed as extremely drug-resistant TB (XDR-TB), Nature News Blog reports.

21 Jan 2012

EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC

MSD today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the use of REMICADE (infliximab) in the treatment of severely active ulcerative colitis (UC) in pediatric patients ages 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies.

21 Jan 2012

Exploring how Peru is addressing drug-resistant TB

Discussing the recent reports of so-called "totally drug-resistant" tuberculosis (TDR-TB) in India, journalist John Donnelly in this GlobalPost "Global Voices" blog entry writes, "Overall, the world is treating drug-resistant TB extraordinarily poorly, and that creates more and more cases of resistant TB that aren't being cured."

21 Jan 2012

Resources dedicated to fighting HIV/AIDS among MSM 'grossly inefficient,' report says

"Funding to prevent and treat HIV/AIDS consistently fails to reach programs designed to control the disease among gay men and other men who have sex with men (MSM), according to a new analysis released Wednesday by amfAR, The Foundation for AIDS Research and the Center for Public Health and Human Rights (CPHHR) at Johns Hopkins University," an amfAR press release states.

21 Jan 2012

Tuberculosis News and Research

Latest Tuberculosis News and Research

Global Health Frontline News examines clean cookstove efforts in Tanzania

Ban calls on business leaders to increase investment in women's education, health at WEF

Nanotechnology firm to develop test for handheld biosensors to detect deadly pathogens

Two initiatives launched at WEF with aim of ending new HIV infections among children by 2015

Addressing TB prevention, treatment among migrant populations

Watching transformation of the Global Fund on its 10th anniversary

Responding to emergence of drug-resistant tuberculosis

Reflecting on Global Fund's decade of accomplishment, looking forward to challenges ahead

Gates pledges $750 million to Global Fund

Gates urges governments, wealthy donors not to cut aid to poor countries; Annual letter sets foundation's priorities

First Edition: January 26, 2012

Latest attacks in Jonglei, South Sudan, perpetuate a pattern of extreme violence, says Médecins Sans Frontières

Address drug resistant pathogens as part of 'next stage of global health'

U.S. should assume leadership role in saving Global Fund

International HIV/AIDS Alliance releases report examining potential effects of Global Fund shortfall

Cooperation needed to fight TB

India's Ministry of Health dismisses claims of 'totally drug-resistant' TB

EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC

Exploring how Peru is addressing drug-resistant TB

Resources dedicated to fighting HIV/AIDS among MSM 'grossly inefficient,' report says

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Tuberculosis News and Research

Latest Tuberculosis News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in